Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers
NHS England has approved two new drug treatments for rare blood cancers, including histiocytic neoplasms and Hodgkin lymphoma. These therapies offer new options for patients who have not responded to standard treatments, with one drug allowing for home-based administration.
Why it matters
These approvals provide life-saving alternatives for patients with limited options and improve quality of life by reducing the need for hospital-based care.
Infants and young children are among hundreds of patients set to receive new life-saving drugs for rare blood cancers.
The article reports on public health policy and medical advancements using neutral, factual language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in